Introduction
Measles still remains as one of the major causes of childhood morbidity and mortality in developing countries 1 . In 2013, it was responsible for 2% of total deaths in children under five years of age 2 . Measles related pneumonia (MRP) is the commonest cause of death in children with measles 3. It may be associated with acute respiratory distress syndrome (ARDS) 4 and pleural effusion (PE) 5 . We describe a case of severe measles related pneumonia with bilateral pleural effusion and ARDS in a 10 month old girl, successfully treated with high dose of methyl prednisolone, vitamin A and intravenous (IV) immunoglobulin during the outbreak in 2013.
Case report
A ten month old girl who was not vaccinated against measles presented to the Sirimavo Bandaranaike Specialized Children's hospital with five days history of high fever, irritability, cough, runny nose, bilateral conjunctivitis and one episode of febrile convulsion. On the third day of the illness a maculopapular rash appeared on the face and neck. On admission, child was drowsy and tachypnoeic with a respiratory rate of 50/min. Initial full blood count showed a white cell count of 5,300/cu mm with 32% lymphocytes __________________________________________ 1 and 60% neutrophils. Her platelet count was 315,000/cu mm with an erythrocyte sedimentation rate (ESR) of 30 mm in the first hour. Child was managed with IV cefuroxime, IV cloxacillin and oral erythromycin with a presumptive diagnosis of MRP with bacterial lower respiratory tract infection. Over the next 48 hours, child's condition deteriorated with increasing respiratory distress, increased work of breathing and hypoxia. Then the patient was intubated and transferred to the medical intensive care unit (MICU) on 7 th day of the illness. Physical examination on admission to MICU revealed generalized maculopapular rash, pulse rate of 167/min and blood pressure of 80/50 mmHg. Chest examination revealed bilaterally reduced breath sounds with dull percussion note. Supine chest radiograph showed bilateral opacities with pleural effusion (Figure 1 Mechanical ventilation was continued for another 5 days and then she was weaned off from the ventilator. She was extubated after 7 days of ventilation and discharged after 12 days of MICU stay.
Discussion
The high mortality rate associated with MRP may be due to its immunosuppressive effects, multisystem involvement and secondary bacterial infection 3 . Irrespective of recent advancements in medicine, there are still no management guidelines except supportive treatment for MRP. Although there is no established treatment protocol, intravenous methyl prednisolone showed some positive results in adults but not in children 6 .
Corticosteroids such as IV methyl prednisolone have proven to reduce inflammation in many diseases.
Methyl prednisolone induces transcription of many genes which produces anti-inflammatory proteins and switch off genes responsible for activation of inflammatory process 7 . A randomized controlled trial in USA revealed that methyl prednisolone administration during early severe ARDS is associated with significant improvement in pulmonary and non-pulmonary organ dysfunction, which in turn reduces the duration of mechanical ventilation 8 .
Vitamin A has been used for decades against measles and showed to have beneficial effects 9 . Furthermore vitamin A deficiency is known to cause many infectious diseases and measles itself reduces the serum vitamin A levels 10 . Current recommendation is to give two doses of Vitamin A to all children with measles 3 .
Intravenous immunoglobulins have been effectively used for the post exposure prevention of measles pneumonia but it's effectiveness for the treatment of MRP is not proven 3 . Because of high mortality, there are some recommendations that hospitalized patients with severe measles may receive a trial of IV Immunoglobulins 3 . As measles itself causes depression of immune system intravenous immunoglobulin may have a positive effect on measles pneumonia.
With this supportive evidence we initiated treatment with IV methyl prednisolone, oral vitamin A and IV immunoglobulins. After initiation of the treatment, patient's condition significantly improved both clinically and radiographically as shown in Figures 1  and 2 . In conclusion, this patient was successfully treated with intravenous methyl prednisolone, vitamin A, immunoglobulin treatment with pleural tap and ventilator support. Rapid response to this treatment should be further investigated as a treatment regime for measles related pneumonia.
